Scholarlink

Background <p>Today, COVID-19 reinfection has raised further public health concerns than its primary infection; which make major global health concern that going to the possibility of COVID-19 re-infection, and how strong the body’s immunity against this disease in individuals with the previous infection. The present study aimed to investigate the probability of COVID-19 re-infection leading to hospitalization in the population referred to hospitals affiliated with Mashhad University of Medical Sciences, Mashhad, Iran.</p> Method <p>The present cross-sectional epidemiological study was conducted on patients referred to hospitals affiliated to the Mashhad University of Medical Sciences, Mashhad, Iran supervision with re-infection of COVID-19 from January 21, 2020, to August 23, 2022. The patients had a definite diagnosis through RT-PCR testing in their first and re-infections, with a time interval of at least one month between the two episodes of infection.</p> Results <p>Out of 125,857 patients evaluated, 9,710 (7.7%) were readmitted with COVID-19 infection more than once, with a time interval of more than one month from their previous hospitalization. The average age of hospitalized patients was 54.8 ± 22.97 years, and more than half were men (51.4%). The most common underlying diseases were hypertension (19.4%) and diabetes (14.8%). cardiovascular diseases, asthma, and cancer were the strongest independent risk factors of COVID-19 re-infection (OR = 2.53, 2.47, and 2.36, respectively, <i>p</i> &lt; 0.001 for all cases).</p> Conclusions <p>In conclusion, our study demonstrates the importance of understanding the risk factors associated with COVID-19 re-infection and re-hospitalization, particularly in vulnerable populations with comorbidities and substance use disorders.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

COVID-19 re-infection: a large cross-sectional population-based study in the northeast of Iran

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月12日

查看全文
  • Mina AkbariRad,
  • Soheila Ehsani Roodi,
  • Mohammadtaghi Shakeri,
  • Maryam Salari,
  • Amir Mohamad Hashem Asnaashari,
  • Abdollah Firoozi,
  • AmirAli Moodi Ghalibaf

摘要

Background

Today, COVID-19 reinfection has raised further public health concerns than its primary infection; which make major global health concern that going to the possibility of COVID-19 re-infection, and how strong the body’s immunity against this disease in individuals with the previous infection. The present study aimed to investigate the probability of COVID-19 re-infection leading to hospitalization in the population referred to hospitals affiliated with Mashhad University of Medical Sciences, Mashhad, Iran.

Method

The present cross-sectional epidemiological study was conducted on patients referred to hospitals affiliated to the Mashhad University of Medical Sciences, Mashhad, Iran supervision with re-infection of COVID-19 from January 21, 2020, to August 23, 2022. The patients had a definite diagnosis through RT-PCR testing in their first and re-infections, with a time interval of at least one month between the two episodes of infection.

Results

Out of 125,857 patients evaluated, 9,710 (7.7%) were readmitted with COVID-19 infection more than once, with a time interval of more than one month from their previous hospitalization. The average age of hospitalized patients was 54.8 ± 22.97 years, and more than half were men (51.4%). The most common underlying diseases were hypertension (19.4%) and diabetes (14.8%). cardiovascular diseases, asthma, and cancer were the strongest independent risk factors of COVID-19 re-infection (OR = 2.53, 2.47, and 2.36, respectively, p < 0.001 for all cases).

Conclusions

In conclusion, our study demonstrates the importance of understanding the risk factors associated with COVID-19 re-infection and re-hospitalization, particularly in vulnerable populations with comorbidities and substance use disorders.